Cite
HARVARD Citation
Steg, P. et al. (2022). Cost–effectiveness of ticagrelor in patients with type 2 diabetes and coronary artery disease: a European economic evaluation of the THEMIS trial. European heart journal. 8 (8), pp. 777-785. [Online].